Esomac D 40 Capsule SR is a combination pharmaceutical formulation containing Domperidone 30mg and Esomeprazole 40mg, designed to manage gastrointestinal disorders associated with acid reflux and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor, suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in gastric parietal cells, providing effective relief from acid-related conditions including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The sustained-release (SR) formulation ensures prolonged therapeutic plasma concentrations, improving symptom control and patient compliance. Esomac D 40 Capsule SR is indicated for the treatment of GERD with associated delayed gastric emptying, Zollinger-Ellison syndrome, and other acid-related disorders requiring acid suppression combined with prokinetic action. It should be used under medical supervision, considering contraindications such as hypersensitivity to components, and caution in patients with cardiac arrhythmias or electrolyte imbalances. Common adverse effects may include headache, dry mouth, abdominal discomfort, and rarely, extrapyramidal symptoms. Dosage and duration of therapy should be individualized based on clinical response and patient tolerance.